drugset
drugset / Trial / NCT02451527

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects

NCT02451527 ↗

Phase 1 Completed 16 enrolled First Affiliated Hospital Xi'an Jiaotong University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetic study of the combination of digoxin and polythylene glycol loxenatide injection (PEX168) in healthy adults，and to provide scientific basis for clinical combination of PEX168 and drugs.This study is also to evaluate the safety and tolerability of mono-digoxin or digoxin plus PEX168.

Timeline

Start
2015-05
Primary completion
2015-09
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.5 mg Oral
Subject PEGLOXENATIDE Peptide 200 ug Subcutaneous

Indications

No indication recorded.